Expert Discusses Promising Early Signals of Napabucasin Combination in Pancreatic Cancer
In results from the phase Ib/II study presented at the 19th World Congress on Gastrointestinal (GI) Cancer, this combination was shown to be safe and demonstrated encouraging signs of efficacy. Read more . . .